To correct for multiple testing, we applied a stringent FDR significance threshold (FDR 0.05)
Recommendations from the American Society of Anesthesiologists for managing GLP-1 therapies perioperatively are available here - GLP-1 therapy perioperative management recommendations
Given the FDAs April 2025 alert, informed consent for compounded topical finasteride should cover systemic absorption risk, known side effects (sexual, neuropsychiatric), transfer risk to household members (especially women of childbearing age), and the non-FDA-approved status of the formulation
The VA data reinforces the systemic benefit of GLP-1 therapy beyond glycemic control, which strengthens the clinical rationale for pursuing alternative coverage pathways rather than discontinuing treatment
N., Chan, M
Thirty-day outcomes of sleeve gastrectomy versus Roux-en-Y gastric bypass: first report based on Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program database